Trends in Internal Medicine
Open AccessImmunotherapy Treatment on Pancreatic Cancer in Adults
Authors: Kailey Wolniakowski, Vincent S Gallicchio.
Abstract
Pancreatic cancer has claimed thousands of lives across the world and currently is one of the most prevalent challenges overtaking the medical community. The cancer once known to only appear in child-related cases has increasingly been affecting middle aged adults. With no defining symptoms, the cancer escapes early detection allowing for the strengthening of the tumor’s microenvironment. Pancreatic cancer is highly malignant, spreading rapidly throughout the body and uses the body's own immune system to feed its attack. Current modes of treatment include radiation therapy, chemotherapy, and surgery, none of which have been found to be consistently successful. With the number of deaths rising, innovative treatment options, such as immunotherapy, are of interest to the medical community. Immunotherapy, which targets the body's natural processes to attack cancerous cells, has been successful in various clinical trials. Further investigation into the biomarkers, mechanisms, and drug combinations to be used in the varying immunotherapy treatments is required.
Editor-in-Chief
View full editorial board →